GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 165 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $10,301,000 | +1694.6% | 430,984 | +965.8% | 0.04% | +2150.0% |
| Q3 2020 | $574,000 | -24.5% | 40,439 | -21.7% | 0.00% | -50.0% |
| Q2 2020 | $760,000 | +125.5% | 51,639 | -26.3% | 0.00% | +300.0% |
| Q4 2019 | $337,000 | -41.6% | 70,054 | -26.5% | 0.00% | -50.0% |
| Q3 2019 | $577,000 | -39.1% | 95,254 | -34.8% | 0.00% | -33.3% |
| Q2 2019 | $948,000 | -7.0% | 146,100 | +1.7% | 0.00% | -25.0% |
| Q1 2019 | $1,019,000 | +961.5% | 143,700 | +858.0% | 0.00% | – |
| Q2 2018 | $96,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
| Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
| Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
| Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
| Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
| Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
| WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |